Guinea

in page functions
[French]
Guinea
Total population (2017) 13,290,655
Birth cohort (2017) 472,039
Surviving Infants (surviving to 1 year per year, 2017) 448,135
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 61/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 94/1000
World Bank Index, IDA (2015) 3.08
Gross Nation Income (per capita US$, 2015) 470
Co-financing group (2017) Initial self-financing
No. of districts/territories (2016) 38

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Guinea

Type of support

Approvals

2001-2021 (US$)
(18 Oct 2017)

Commitments

2001-2021 (US$)
(18 Oct 2017)

Disbursements

2000-2017 (US$)
(18 Oct 2017)

% Disbursed

(18 Oct 2017)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $71,353,356 $84,368,028 $43,539,046
Cold Chain Equipment Optimisation Platform (CCEOP) $8,749,076 $8,749,076
Ebola EPI Recovery Plan (EEPIRP) $6,050,152 $6,050,152 $6,050,152 100%
Health system strengthening (HSS 1) $2,134,500 $2,134,500 $2,134,500 100%
Health system strengthening (HSS 2) $18,905,807 $26,499,978
HepB mono (NVS) $665,106 $665,106 $665,106 100%
Immunisation services support (ISS) $2,918,900 $2,918,900 $2,918,900 100%
Injection Safety Devices (NVS) $79,000 $353,500 $68,995 87%
Injection safety support (INS) $347,460 $347,460 $347,460 100%
IPV (NVS) $1,126,000 $1,126,000 $967,499 86%
Meningitis A - campaign (NVS) $2,522,744 $2,522,744 $2,522,744 100%
Meningitis A - operational costs (OPC) $2,321,536 $2,321,536 $2,321,536 100%
Penta (NVS) $20,935,228 $24,702,228 $20,821,965 99%
Vaccine Introduction Grant (VIG) $577,000 $577,000 $577,000 100%
Yellow Fever (NVS) $4,020,847 $5,399,847 $4,143,189 103%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Guinea DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 66%
M:F sex ratio at birth (2017) 1.02
Household survey: DTP3 coverage for male (2011) 52.30%
Household survey: DTP3 coverage for female (2011) 47.00%
Household survey: Last DTP3 survey (2011) 50%
% districts achieving > 80% DTP3 coverage (2016) 87%
% districts achieving < 50% DTP3 coverage (2016) 0%
MCV WHO/UNICEF estimates (2016) 54%

Breakdown of support

Non-vaccine support Vaccine support
33% 67%
$14,349,548 $29,189,498

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Guinea

30 November 2017

Gavi Board Dec 2017 - Nasala village visit

Millions of children set to be protected against typhoid fever

Gavi Board approves US$ 85 million funding window for 2019-2020 to support the introduction of typhoid conjugate vaccine in developing countries.

21 November 2017

Gavi Board meeting, 29-30 November 2017

The Gavi Board meeting was held in Vientiane, Lao PDR on 29-30 November 2017.

24 October 2017

Aspen statement - Gavi CEO Seth Berkley and Peggy Clark, ED, Aspen Global Innovators Group

Gavi and the Aspen Institute to strengthen health management capacity in developing countries

Malawi will be the first country to benefit from the new partnership .

close icon

modal window here